We are live on ! Find out more
ANAB icon

AnaptysBio

121 hedge funds and large institutions have $1.85B invested in AnaptysBio in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 36 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more call options, than puts

Call options by funds: $11.7M | Put options by funds: $7.74M

28% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 36

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.37% less ownership

Funds ownership: 108.67%108.3% (-0.37%)

6% less funds holding

Funds holding: 129121 (-8)

28% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 29

35% less capital invested

Capital invested by funds: $2.85B → $1.85B (-$1B)

Holders
121
Holders Change
-8
Holders Change %
-6.2%
% of All Funds
2.7%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
21
Increased
46
Reduced
36
Closed
29
Calls
$11.7M
Puts
$7.74M
Net Calls
+$3.92M
Net Calls Change
-$47.2M
Name Holding Trade Value Shares
Change
Change in
Stake
TA
51
Teachers Advisors
New York
$3.23M +$944K +12,693 +33%
Two Sigma Advisers
52
Two Sigma Advisers
New York
$3.15M -$870K -11,700 -19%
TCIM
53
TIAA CREF Investment Management
New York
$3M -$113K -1,520 -3%
Lord, Abbett & Co
54
Lord, Abbett & Co
New Jersey
$2.59M -$10.5M -140,824 -78%
UBS Group
55
UBS Group
Switzerland
$2.51M +$1.86M +24,969 +173%
California State Teachers Retirement System (CalSTRS)
56
California State Teachers Retirement System (CalSTRS)
California
$2.11M +$299K +4,026 +14%
Hudson Bay Capital Management
57
Hudson Bay Capital Management
Connecticut
$1.91M +$2.23M +30,000 New
Swiss National Bank
58
Swiss National Bank
Switzerland
$1.9M
American Century Companies
59
American Century Companies
Missouri
$1.88M -$61.6K -829 -3%
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$1.8M +$818K +11,001 +64%
LCM
61
Laurion Capital Management
New York
$1.77M +$927K +12,460 +82%
California Public Employees Retirement System
62
California Public Employees Retirement System
California
$1.61M +$393K +5,282 +27%
SI
63
Sofinnova Investments
California
$1.59M -$3.32M -44,595 -64%
Susquehanna International Group
64
Susquehanna International Group
Pennsylvania
$1.43M -$291K -3,918 -15%
FI
65
Fosun International
China
$1.33M +$1.61M +21,596 New
State of Wisconsin Investment Board
66
State of Wisconsin Investment Board
Wisconsin
$1.25M +$52.1K +700 +4%
New York State Common Retirement Fund
67
New York State Common Retirement Fund
New York
$1.19M -$338K -4,539 -20%
SEI Investments
68
SEI Investments
Pennsylvania
$1.1M
Russell Investments Group
69
Russell Investments Group
United Kingdom
$1.02M -$159K -2,144 -12%
First Trust Advisors
70
First Trust Advisors
Illinois
$957K +$1.12M +14,996 New
Barclays
71
Barclays
United Kingdom
$911K -$8.2M -110,318 -89%
TD Asset Management
72
TD Asset Management
Ontario, Canada
$900K +$96.7K +1,300 +10%
AIG
73
American International Group
New York
$887K +$97.8K +1,315 +10%
CS
74
Credit Suisse
Switzerland
$878K +$516K +6,945 +102%
ECM
75
Endurant Capital Management
California
$812K +$947K +12,734 New

ANAB Hedge Fund Activity: Q4 2018 in Review

121 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q4 2018, worth a combined $1.85B — down 35% from $2.85B a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of ANAB and 21 opened new positions — a net loss of 8 holders — while 36 trimmed existing stakes and 46 added.

The largest buyer was Adage Capital Partners, adding an estimated $74M. The largest seller was PFM Health Sciences, cutting an estimated $33.4M.

  • 121 institutional investors held AnaptysBio (ANAB) as of Q4 2018, down from 129 in Q3 2018.
  • Funds reported $1.85B of AnaptysBio stock for Q4 2018, down 35% quarter-over-quarter.
  • 21 funds opened new AnaptysBio positions in Q4 2018 and 29 closed out, a net change of -8 holders.
  • The largest AnaptysBio buyer in Q4 2018 was Adage Capital Partners, an estimated $74M added.
  • The largest AnaptysBio seller in Q4 2018 was PFM Health Sciences, an estimated $33.4M sold.

Based on aggregated 13F filings for Q4 2018.